Nebenwirkungen · MenQuadfi
MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine MenACWY · Abschnitt 4.8 · PDF-Seite 10
HOS-144234 · Präparat HOS-099130
Not known Hypersensitivity1 Metabolism and nutrition disorders Very common Appetite lost Psychiatric disorders Very common Irritability Uncommon Insomnia3 Nervous system disorders Very common Drowsiness Not known Febrile convulsions1, seizures1 Vascular disorders Rare Flushing Gastrointestinal disorders Very common Vomiting2 Common Diarrhoea3 Skin and subcutaneous tissue Uncommon Urticaria3, rash disorder Rare Petechiae, erythema General disorders and Very common Fever, abnormal crying administration site conditions At the injection site: tenderness /pain, erythema, swelling Common At the injection site: bruising At the injection site: haemorrhage, Uncommon induration, rash, warmth, pruritus3 Not known At the injection site: cellulitis1 1 ADR identified from post-marketing reporting 2 Less frequent in toddlers 12 months through 23 months 3 Less frequent in infants initiating vaccination at 6 weeks through 11 months of age
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-18T10:00:00Z · SHA-256 ebec4745bfdc370a0e03b2fca938d4349a0aa60a9b6f828972f5fba03ef36517 · Passage 6533a7eed31f741dc8263eb6162b0773cf5f477eb0bfcb24de43527d6ecd9cf6 · Zeichen 6712–8440 im Abschnitt